Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

LON/0QW5 stock hub

LON/0QW5 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0QW5is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

110.3M

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0QW5

In the news

Latest news · LON/0QW5

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-820

P25 n/aP50 n/aP75 n/a

ROIC-581.8

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0QW5 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

170

Groups with data

Currency

EUR

Showing 170 of 170 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Germany
Country code	UK
Employees	111
Employees Change	6%
Employees Change Percent	5.71
Enterprise value	EUR 102.4M
Exchange	London Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Isin	DE000A11QVV0
Last refreshed	2026-05-10
Market cap	EUR 110.3M
Price	EUR 2.75
Price currency	EUR
Rev Per Employee	20,975.55x
Sic	2836
Symbol	lon/0QW5
Website	https://heidelberg-pharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-32.32%
EV Earnings	-2.87x
EV/FCF	-3.98x
EV/Sales	44.7x
FCF yield	-23.32%
P/B ratio	-8.29x
P/S ratio	47.38x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	77.28%
Gross Profit	EUR 1.8M
Gross Profit Growth	-69.23%
Gross Profit Growth Q	201.19%
Gross Profit Growth3 Y	-47.76%
Gross Profit Growth5 Y	-1.35%
Net Income	EUR -35.7M
Pretax Margin	-1,492.08%
Profit Per Employee	EUR -321,280
ROA	-70.55
Roa5y	-39.93
ROCE	-216.9
ROE	-820
Roe5y	-165.6
ROIC	-581.8

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	4.33%
Cagr1y	-12.98%
Cagr3y	-12.74%
Cagr5y	-16.22%
Revenue Growth	-68.64x
Revenue Growth Q	220.19x
Revenue Growth3 Y	-48.9x
Revenue Growth5 Y	-18.47x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.06
Assets	EUR 27M
Cash	EUR 8.1M
Current Assets	EUR 18.7M
Current Liabilities	EUR 7.8M
Debt	EUR 67,958
Debt FCF	EUR -0
Equity	EUR -13.3M
Interest Coverage	-11,531.2
Liabilities	EUR 40.3M
Long Term Assets	EUR 8.3M
Long Term Liabilities	EUR 32.5M
Net Cash	EUR 8.1M
Net Cash By Market Cap	EUR 7.31
Net Cash Growth	-55.26%
Tangible Book Value	EUR -21M
Tangible Book Value Per Share	EUR -0.44
WACC	8.5

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.4
Inventory Turnover	0.05
Net Working Capital	EUR 2.9M
Quick ratio	1.29
Working Capital	EUR 11.1M
Working Capital Turnover	EUR 0.1

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.72%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	52.82%
1Y total return	-12.97%
200-day SMA	3.41
3Y total return	-33.57%
50-day SMA	2.9
50-day SMA vs 200-day SMA	50under200
5Y total return	-58.71%
All Time High	8.42
All Time High Change	-67.32%
All Time High Date	2021-06-22
All Time Low	1.42
All Time Low Change	94.35%
All Time Low Date	2016-08-25
ATR	0.09
Beta	0.77
Ch YTD	12.71
High	2.75
High52	5.42
High52 Date	2025-06-06
High52ch	-49.26%
Low	2.75
Low52	2.32
Low52 Date	2025-12-23
Low52ch	18.53%
Ma50ch	-5.11%
Price vs 200-day SMA	-19.28%
RSI	46.72
RSI Monthly	44.99
RSI Weekly	42.4
Sharpe ratio	0.4x
Sortino ratio	0.66
Total Return	-0.72%
Tr YTD	12.71
Tr1m	-7.72%
Tr1w	-3.17%
Tr3m	-5.82%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -41.4M
Operating margin	-1,779

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	9,966,385%
Net Borrowing	-111,921.3
Shares Insiders	2.31%
Shares Institutions	0.73%
Shares Qo Q	2.57%
Shares Yo Y	0.72%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -25.7M
Average Volume	264.85x
Bv Per Share	-0.28
CAPEX	EUR -36,422
Ch10y	52.69
Ch1m	-7.72
Ch1w	-3.17
Ch1y	-12.97
Ch3m	-5.82
Ch3y	-33.57
Ch5y	-58.71
Ch6m	-11.86
Change	-2.83%
Change From Open	0
Close	2.83
Days Gap	-2.83
Depreciation Amortization	480,624.6
Dollar Volume	467.5
Earnings Date	2026-07-15
EBIT	EUR -41.4M
EBITDA	EUR -40.9M
EPS	EUR -0.76
F Score	1
FCF	EUR -25.7M
FCF EV Yield	-25.13x
Financing CF	16,104,783
Fiscal Year End	November
Founded	1,997
Goodwill	5,286,352.2
Income Tax	EUR 922,104
Investing CF	502,269
Is Primary Listing	0
Last Earnings Date	2026-03-26
Last Report Date	2026-02-28
Last Split Date	2017-11-07
Last Split Type	Forward
Ma150	3.2
Ma150ch	-14.09%
Ma20	2.77
Ma20ch	-0.83%
Net CF	-10,024,028
Next Earnings Date	2026-07-15
Open	2.75
Ppne	215,652.4
Price Date	2026-05-08
Relative Volume	0.64x
Revenue	2,328,286x
SBC By Revenue	0.55x
Share Based Comp	12,714
Tax By Revenue	39.6x
Tr6m	-11.86%
Volume	170

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0QW5 pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0QW5 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0QW5?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.7%

Share of float held by funds and institutions

Insider ownership

+2.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.7%

Negative means the company is buying back shares.

Technical

LON/0QW5 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

46.7

Neutral momentum band

Price vs 200-day MA

-19.3%

50/200-day relationship not available

Beta (5Y)

0.77

Less volatile than the market

Sharpe ratio

0.40

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0QW5

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0QW5 stock rating?

lon/0QW5 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0QW5 analysis?

The full report lives at /stocks/lon/0QW5/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0QW5?

The latest report frames lon/0QW5 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0QW5 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.